The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The purpose of this study is to evaluate early fixation and stability of the Tritanium cup. It is expected that the Tritanium® cup will be equal to or better than conventional cementless cups in early fixation/stability and meet the expectations of Japanese surgeons.
Condition or disease
OsteoarthritisRheumatoid ArthritisAvascular Necrosis of the Femoral Head
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
20 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patient who has diagnosis of secondary osteoarthritis, avascular necrosis and rheumatoid arthritis
Patient is a candidate for a primary Total Hip Arthroplasty (THA).
Patient who has diagnosis of secondary osteoarthritis, avascular necrosis and rheumatoid arthritis.
Patient whose age is 20 or over.
Patient who signed an Institutional Review Board (IRB)-approved, study specific Informed Patient Consent Form.
Patient who is willing and able to comply with postoperative scheduled evaluations.
Patient who has a bacterial infectious disease or has a high risk of a bacterial infection.
Patient who requires revision surgery of a previously implanted total hip arthroplasty.
Patient who is morbidly obese, defined as having a Body Mass Index (BMI) > 40.
Patient who is or may be pregnant female.
Patient who has neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device.
Patient with diagnosed systemic disease (i.e. Paget's disease, renal osteodystrophy), which limits ability to evaluate the safety and efficacy of the device.
Patient who is immunologically suppressed or receiving chronic steroids, which limits ability to evaluate the safety and efficacy of the device.
Patients who is judged ineligible with specific reason by primary doctor.